TLR3 and viral infectious disease: Poly(I:C) was selected as the molecular adjuvant due its close association with viral infection, we speculated it may be able to induce an antiviral Th1/cytotoxic skewed immune response, similar to that of a virus, furthermore BVDV has been shown to modify TLR3 expression potentially as an immunological escape mechanism41–43.